Taught course

Cancer Therapeutics

Institution
Barts and the London School of Medicine and Dentistry · Barts and the London School of Medicine and Dentistry
Qualifications
MScPGDipPGCert

Entry requirements

The programme is open to graduate scientists, clinicians and other medical professionals working in healthcare, the pharmaceutical industry or contract research organisations. Previous lab experience is not required but applicants should have a minimum 2:2 degree in relevant subject (eg, biology/chemistry/pharmacology/medicine), or degree equivalent qualification, from a recognised academic institution or an appropriate professional qualification or experience. International applicants Students from outside of the UK help form a global community here at Queen Mary. For detailed country specific entry requirements please visit the International section of our website. If your first language is not English, you must provide evidence of your English language proficiency. Find out more about our English language entry requirements. If you do not meet language or scholarly requirements it might be possible for you to undertake foundation or pre-sessional programmes that will prepare you for the masters programme. For more information, please contact the Admissions Office.

Months of entry

September

Course content

This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of cancer therapeutics and the development, evaluation and implementation of new treatments. This is underpinned by a thorough knowledge of cancer biology and pathology, research methodologies, drug development and regulatory issues. There is an emphasis on practical skills during the research skills module and the three-month laboratory project.

This programme will give you a comprehensive and holistic insight into the field of Cancer Therapeutics, covering all stages from the very basic cell and molecular biology underlying the development and pathogenesis of cancer as a disease, through pharmacology, drug development, novel therapeutics and cancer screening.

By undertaking this course you will be contributing to the growing need for scientists and clinicians to identify and promote the practical uses of molecular advances in pathology in the clinical environment.

This programme will:

  • Give you a thorough grounding in the principles underlying cancer treatment
  • Introduce you to the regulatory framework underlying clinical research
  • Give you an understanding of the principles of laboratory methodologies applied to clinical trials
  • Show you the steps involved in developing and implementing new treatments and how to apply this knowledge in your professional role
  • Encourage you to contribute to the research activity and knowledge base in improving cancer care.

Qualification and course duration

MSc

part time
24 months
full time
12 months

PGDip

part time
24 months
full time
12 months

PGCert

full time
12 months
part time
24 months

Course contact details

Name
Dr Richard Grose
Email
r.p.grose@qmul.ac.uk
Phone
+44(0)20 7882 2081